2022 annual financial data
Rhythm Pharmaceuticals 2022 Net income growth
Direct answer
Net income growth was -166.32%.
Operating income was -179,157,000 USD and net income was -181,119,000 USD.
Operating cash flow was -173,428,000 USD.
Get free Rhythm Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,638,000 USD
- Operating income
- -179,157,000 USD
- Net income
- -181,119,000 USD
- Operating cash flow
- -173,428,000 USD